Evidence map›Paper›PMID 28855241›Full record

ArticleThe Journal of experimental medicine2017

RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.

Lance W Peterson, Naomi H Philip, Alexandra DeLaney, Meghan A Wynosky-Dolfi, Kendra Asklof, Falon Gray, Ruth Choa, Elisabet Bjanes, Elisabeth L Buza, Baofeng Hu and 6 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Innate detection ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Raver1 linksProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. TLR priming licenses NAIP inflammasome activation by immunoevasive ligands.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lance W PetersonDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.ORCID http://orcid.org/0000-0003-2458-6678
Naomi H PhilipDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Alexandra DeLaneyDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Meghan A Wynosky-DolfiDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Kendra AsklofDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Falon GrayDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Ruth ChoaDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.ORCID http://orcid.org/0000-0002-4798-7565
Elisabet BjanesDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Elisabeth L BuzaDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.
Baofeng HuDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA.ORCID http://orcid.org/0000-0002-8641-6693
Christopher P DillonDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN.
Scott B BergerHost Defense Discovery Performance Unit, Infectious Disease Therapy Area Unit, GlaxoSmithKline, Collegeville, PA.
Peter J GoughHost Defense Discovery Performance Unit, Infectious Disease Therapy Area Unit, GlaxoSmithKline, Collegeville, PA.ORCID http://orcid.org/0000-0002-5110-9300
John BertinPattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA.
Igor E BrodskyDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA ibrodsky@vet.upenn.edu.ORCID http://orcid.org/0000-0001-7970-872X

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007170 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE F · 1985 to 2022
$54.0M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Survival Function of the Fadd-Caspase-8-Flip ComplexR01AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1999 to 2016
$6.3M
TRAINING PROGRAM/RHEUMATIC DISEASEST32AR007442 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BEHRENS, EDWARD M, MERKEL, PETER A · 1986 to 2018
$5.8M
Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT ExtensionR37AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2017 to 2026
$4.5M
Defining the non-apoptotic role of Caspase-8 activity in anti-bacterial immune defenseR01AI128530 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2017 to 2021
$2.0M
Modulation of Inflammasome Activation by YersiniaR01AI103062 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2013 to 2016
$1.7M
Dissecting the mechanism of RIPK1 kinase-dependent cell death in control of Yersinia infectionR21AI125924 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2016 to 2017
$459k
Role of Caspase-8 in Yersinia virulence and host defenseR21AI109267 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2014 to 2015
$440k
NIAID NIH HHS R01 AI044828NIAID NIH HHS R01 AI103062NIAID NIH HHS R01 AI128530NIAID NIH HHS R21 AI109267NIAID NIH HHS R21 AI125924NIAID NIH HHS R37 AI044828NIAMS NIH HHS T32 AR007442NIDDK NIH HHS P30 DK050306
6 · The paper itself

Abstract

Many pathogens deliver virulence factors or effectors into host cells in order to evade host defenses and establish infection. Although such effector proteins disrupt critical cellular signaling pathways, they also trigger specific antipathogen responses, a process termed "effector-triggered immunity." The Gram-negative bacterial pathogen

Indexed as

AnimalsApoptosisCytokinesDisease ResistanceHost-Pathogen InteractionsImmunity, InnateMacrophagesMAP Kinase Signaling SystemMice, Inbred C57BLMice, KnockoutModels, ImmunologicalNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesSignal TransductionSurvival AnalysisYersinia pseudotuberculosisCytokinesNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouse

Identifiers

PMID28855241
PMCPMC5679171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.